{
    "nctId": "NCT02190539",
    "briefTitle": "Homeopathic Protocol for Advanced Breast Cancer",
    "officialTitle": "The Banerji Protocol for Advanced Breast Cancer- Feasibility Study",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "To establish if patients with advanced breast cancer in Meir Oncology Institute would follow a homeopathic treatment protocol as used by Dr Banerji in India, for six months.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years of age or older\n* Ability to speak and read Hebrew/English with patients residing in Israel.\n* Diagnosis of advanced breast cancer treated and followed in Meir Oncology Institute\n* Patients that cannot participate in conventional cancer care due to side effects, expected adverse reactions or other reasons that prevent them from utilizing conventional care.\n* Patients, who for their own reasons elect to refuse conventional treatment, can be offered to participate in the study in order to keep them in the system and not lose them to alternative untested treatments.\n* Consent to participate in this study\n\nExclusion Criteria:\n\n* Inability to understand the intent of the study and follow the instructions\n* Medical condition that would preclude participation in an interview session lasting 15-30 minutes\n* Diagnosis of active psychosis or severe cognitive impairment confirmed by the patient's attending physician.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}